Parity and Decreased Use of Oral Contraceptives As Predictors of Asthma in Young Women
Overview
Authors
Affiliations
Background: Asthma is more prevalent among males in childhood, but females report higher rates in adulthood. The reasons are unknown; although it has been hypothesized that hormonal factors may explain this sex-dependent risk of adult-onset asthma.
Objective: To determine whether a woman's reproductive history or use of oral contraceptives is associated with adult-onset asthma.
Methods: In 1991-1993, we surveyed 681 women aged 29-32 years randomly sampled from participants first surveyed at age 7 years by the 1968 Tasmanian Asthma Survey, a study of all children born in 1961 and attending school. Current asthma was defined as reporting asthma or wheezy breathing in the past 12 months.
Results: In women who did not have asthma or wheezy breathing by age 7 years, 13% had current asthma. The risk of current asthma in these who were parous increased with the number of births (odds ratio (OR) 1.50 per birth, 95% confidence interval (CI) 1.01-2.23 P=0.04) while women with one birth were at a lower risk than nulliparous women (OR 0.46 95% CI 0.2-1.06, P=0.07). Independent of parity, the risk decreased by 7% (95% CI 0-13%) per year of oral contraceptive pill use in all women. In women who did have asthma or wheezy breathing by age 7 years, neither reproductive history nor oral contraceptive pill use predicted current asthma.
Conclusion: Our observation that parity and decreased oral contraceptive use predict asthma in women, is consistent with the hypothesis that the asthma that develops after childhood is in part a response to endogenous and exogenous female hormones. This may be due to alterations of cytokine responses by the pregnant state, triggering adult-onset asthma in women.
Phytoestrogen-Based Hormonal Replacement Therapy Could Benefit Women Suffering Late-Onset Asthma.
Sommer B, Gonzalez-Avila G, Flores-Soto E, Montano L, Solis-Chagoyan H, Romero-Martinez B Int J Mol Sci. 2023; 24(20).
PMID: 37895016 PMC: 10607548. DOI: 10.3390/ijms242015335.
Epidemiology of Asthma: Prevalence and Burden of Disease.
Merhej T, Zein J Adv Exp Med Biol. 2023; 1426:3-23.
PMID: 37464114 DOI: 10.1007/978-3-031-32259-4_1.
Wang Y, Tzeng J, Huang Y, Maguire R, Hoyo C, Allen T Environ Epigenet. 2023; 9(1):dvac026.
PMID: 36694712 PMC: 9854336. DOI: 10.1093/eep/dvac026.
Nguyen T, Smith C, Gazzuola Rocca L, Rocca W, Vassallo R, Dulohery Scrodin M NPJ Prim Care Respir Med. 2022; 32(1):52.
PMID: 36376327 PMC: 9663719. DOI: 10.1038/s41533-022-00317-4.
Hormonal Effects on Asthma, Rhinitis, and Eczema.
Weare-Regales N, Chiarella S, Cardet J, Prakash Y, Lockey R J Allergy Clin Immunol Pract. 2022; 10(8):2066-2073.
PMID: 35436605 PMC: 9392967. DOI: 10.1016/j.jaip.2022.04.002.